NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported that its third quarter revenues jumped 31 percent year over year as the firm surpassed the consensus analyst estimate on the bottom line but missed it on the top line.

For the three months ended Sept. 27, Thermo Fisher said total revenues increased to $4.17 billion from $3.19 billion in the year-ago period, but were below the consensus Wall Street expectation of $4.21 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.